Oligomerix is seeking solutions to major unmet medical needs with over 10 years research experience in helping define the role of tau protein in neurodegenerative diseases and discovering and developing novel therapeutics for Alzheimer’s and related tauopathies.
Our objective was to emphasize the unique science of the company, its candidates and their relative state of development and appeal to multiple audiences, including Pharma Companies, Venture Capitalists, Researchers, job seekers.
